Information on how insulin and insulin-like growth factors 1 and 2 (IGF-1 and -2) activate insulin receptors (IR-A and -B) and the IGF-1 receptor (IGF-1R) is crucial for understanding the difference in the biological activities of these peptide hormones. Cryo-EM studies have revealed that insulin uses its binding sites 1 and 2 to interact with IR-A and have identified several critical residues in binding site 2. However, mutagenesis studies suggest that Ile-A10, Ser-A12, Leu-A13, and Glu-A17 also belong to insulin's site 2. Here, to resolve this discrepancy, we mutated these insulin residues and the equivalent residues in IGFs. Our findings revealed that equivalent mutations in the hormones can result in differential biological effects and that these effects can be receptor-specific. We noted that the insulin positions A10 and A17 are important for its binding to IR-A and IR-B and IGF-1R and that A13 is important only for IR-A and IR-B binding. The IGF-1/IGF-2 positions 51/50 and 54/53 did not appear to play critical roles in receptor binding, but mutations at IGF-1 position 58 and IGF-2 position 57 affected the binding. We propose that IGF-1 Glu-58 interacts with IGF-1R Arg-704 and belongs to IGF-1 site 1, a finding supported by the NMR structure of the less active Asp-58-IGF-1 variant. Computational analyses indicated that the aforementioned mutations can affect internal insulin dynamics and inhibit adoption of a receptor-bound conformation, important for binding to receptor site 1. We provide a molecular model and alternative hypotheses for how the mutated insulin residues affect activity.

Institute of Molecular Genetics Czech Academy of Sciences 166 37 Prague 6 Czech Republic

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences 166 10 Prague 6 Czech Republic

Zobrazit více v PubMed

De Meyts P. (2004) Insulin and its receptor: structure, function and evolution. Bioessays 26, 1351–1362 10.1002/bies.20151 PubMed DOI

Le Roith D. (2003) The insulin-like growth factor system. Exp. Diabesity Res. 4, 205–212 10.1155/EDR.2003.205 PubMed DOI PMC

Ward C. W., and Lawrence M. C. (2012) Similar but different: ligand-induced activation of the insulin and epidermal growth factor receptor families. Curr. Opin. Struct. Biol. 22, 360–366 10.1016/j.sbi.2012.03.014 PubMed DOI

Lemmon M. A., and Schlessinger J. (2010) Cell signaling by receptor tyrosine kinases. Cell 141, 1117–1134 10.1016/j.cell.2010.06.011 PubMed DOI PMC

Belfiore A., Malaguarnera R., Vella V., Lawrence M. C., Sciacca L., Frasca F., Morrione A., and Vigneri R. (2017) Insulin receptor isoforms in physiology and disease: An updated view. Endocr. Rev. 38, 379–431 10.1210/er.2017-00073 PubMed DOI PMC

Slaaby R. (2015) Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin. Sci. Rep. 5, 7911 10.1038/srep07911 PubMed DOI PMC

Jiracek J., and Zakova L. (2017) Structural perspectives of insulin receptor isoform-selective insulin analogs. Front. Endocrinol. (Lausanne) 8, 167 10.3389/fendo.2017.00167 PubMed DOI PMC

Clemmons D. R. (2016) Role of IGF binding proteins in regulating metabolism. Trends Endocrinol. Metab. 27, 375–391 10.1016/j.tem.2016.03.019 PubMed DOI

Kornfeld S. (1992) Structure and function of the mannose 6-phosphate insulin-like growth factor-II receptors. Annu. Rev. Biochem. 61, 307–330 10.1146/annurev.bi.61.070192.001515 PubMed DOI

Williams C., Hoppe H. J., Rezgui D., Strickland M., Forbes B. E., Grutzner F., Frago S., Ellis R. Z., Wattana-Amorn P., Prince S. N., Zaccheo O. J., Nolan C. M., Mungall A. J., Jones E. Y., Crump M. P., et al. (2012) An exon splice enhancer primes IGF2:IGF2R binding site structure and function evolution. Science 338, 1209–1213 10.1126/science.1228633 PubMed DOI PMC

Brody H. (2012) Diabetes. Nature 485, S1 10.1038/485S1a PubMed DOI

Gallagher E. J., and LeRoith D. (2010) Insulin, insulin resistance, obesity, and cancer. Curr. Diab. Rep. 10, 93–100 10.1007/s11892-010-0101-y PubMed DOI

Craft S. (2012) Insulin resistance and AD-extending the translational path. Nat. Rev. Neurol. 8, 360–362 10.1038/nrneurol.2012.112 PubMed DOI

Kiselyov V. V., Versteyhe S., Gauguin L., and De Meyts P. (2009) Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation. Mol. Syst. Biol. 5, 243 10.1038/msb.2008.78 PubMed DOI PMC

Schäffer L. (1994) A model for insulin binding to the insulin receptor. Eur. J. Biochem. 221, 1127–1132 10.1111/j.1432-1033.1994.tb18833.x PubMed DOI

Menting J. G., Whittaker J., Margetts M. B., Whittaker L. J., Kong G. K., Smith B. J., Watson C. J., Záková L., Kletvíková E., Jiráček J., Chan S. J., Steiner D. F., Dodson G. G., Brzozowski A. M., Weiss M. A., et al. (2013) How insulin engages its primary binding site on the insulin receptor. Nature 493, 241–245 10.1038/nature11781 PubMed DOI PMC

Menting J. G., Yang Y., Chan S. J., Phillips N. B., Smith B. J., Whittaker J., Wickramasinghe N. P., Whittaker L. J., Pandyarajan V., Wan Z. L., Yadav S. P., Carroll J. M., Strokes N., Roberts C. T. Jr., Ismail-Beigi F., et al. (2014) Protective hinge in insulin opens to enable its receptor engagement. Proc. Natl. Acad. Sci. U.S.A. 111, E3395–E3404 10.1073/pnas.1412897111 PubMed DOI PMC

Menting J. G., Lawrence C. F., Kong G. K., Margetts M. B., Ward C. W., and Lawrence M. C. (2015) Structural congruency of ligand binding to the insulin and insulin/type 1 insulin-like growth factor hybrid receptors. Structure 23, 1271–1282 10.1016/j.str.2015.04.016 PubMed DOI

Xu Y. B., Kong G. K., Menting J. G., Margetts M. B., Delaine C. A., Jenkin L. M., Kiselyov V. V., De Meyts P., Forbes B. E., and Lawrence M. C. (2018) How ligand binds to the type 1 insulin-like growth factor receptor. Nat. Commun. 9, 821 10.1038/s41467-018-03219-7 PubMed DOI PMC

De Meyts P. (2015) Insulin/receptor binding: The last piece of the puzzle? Bioessays 37, 389–397 10.1002/bies.201400190 PubMed DOI

Scapin G., Dandey V. P., Zhang Z., Prosise W., Hruza A., Kelly T., Mayhood T., Strickland C., Potter C. S., and Carragher B. (2018) Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis. Nature 556, 122–125 10.1038/nature26153 PubMed DOI PMC

Weis F., Menting J. G., Margetts M. B., Chan S. J., Xu Y., Tennagels N., Wohlfart P., Langer T., Müller C. W., Dreyer M. K., and Lawrence M. C. (2018) The signalling conformation of the insulin receptor ectodomain. Nat. Commun. 9, 4420 10.1038/s41467-018-06826-6 PubMed DOI PMC

Gauguin L., Klaproth B., Sajid W., Andersen A. S., McNeil K. A., Forbes B. E., and De Meyts P. (2008) Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor. J. Biol. Chem. 283, 2604–2613 10.1074/jbc.M709220200 PubMed DOI

Alvino C. L., McNeil K. A., Ong S. C., Delaine C., Booker G. W., Wallace J. C., Whittaker J., and Forbes B. E. (2009) A novel approach to identify two distinct receptor binding surfaces of insulin-like growth factor II. J. Biol. Chem. 284, 7656–7664 10.1074/jbc.M808061200 PubMed DOI PMC

Delaine C., Alvino C. L., McNeil K. A., Mulhern T. D., Gauguin L., De Meyts P., Jones E. Y., Brown J., Wallace J. C., and Forbes B. E. (2007) A novel binding site for the human insulin-like growth factor-II (IGF-II)/mannose 6-phosphate receptor on IGF-II. J. Biol. Chem. 282, 18886–18894 10.1074/jbc.M700531200 PubMed DOI

Hexnerová R., Křížková K., Fábry M., Sieglová I., Kedrová K., Collinsová M., Ullrichová P., Srb P., Williams C., Crump M. P., Tošner Z., Jiráček J., Veverka V., and Žáková L. (2016) Probing receptor specificity by sampling the conformational space of the insulin-like growth factor II C-domain. J. Biol. Chem. 291, 21234–21245 10.1074/jbc.M116.741041 PubMed DOI PMC

Kosinová L., Veverka V., Novotná P., Collinsová M., Urbanová M., Moody N. R., Turkenburg J. P., Jiráček J., Brzozowski A. M., and Žáková L. (2014) Insight into the structural and biological relevance of the T/R transition of the N-terminus of the B-chain in human insulin. Biochemistry 53, 3392–3402 10.1021/bi500073z PubMed DOI PMC

Křížková K., Veverka V., Maletínská L., Hexnerová R., Brzozowski A. M., Jiráček J., and Žáková L. (2014) Structural and functional study of the GlnB22-insulin mutant responsible for maturity-onset diabetes of the young. PLoS One 9, e112883 10.1371/journal.pone.0112883 PubMed DOI PMC

Macháčková K., Collinsová M., Chrudinová M., Selicharová I., Pícha J., Buděšínský M., Vaněk V., Žáková L., Brzozowski A. M., and Jiráček J. (2017) Insulin-like growth factor 1 analogs clicked in the C domain: chemical synthesis and biological activities. J. Med. Chem. 60, 10105–10117 10.1021/acs.jmedchem.7b01331 PubMed DOI

Macháčková K., Chrudinová M., Radosavljević J., Potalitsyn P., Křížková K., Fábry M., Selicharová I., Collinsová M., Brzozowski A. M., Žáková L., and Jiráček J. (2018) Converting insulin-like growth factors 1 and 2 into high-affinity ligands for insulin receptor isoform A by the introduction of an evolutionarily divergent mutation. Biochemistry 57, 2373–2382 10.1021/acs.biochem.7b01260 PubMed DOI

Záková L., Kletvíková E., Lepšík M., Collinsová M., Watson C. J., Turkenburg J. P., Jiráček J., and Brzozowski A. M. (2014) Human insulin analogues modified at the B26 site reveal a hormone conformation that is undetected in the receptor complex. Acta Crystallogr. D. 70, 2765–2774 10.1107/S1399004714017775 PubMed DOI PMC

Papaioannou A., Kuyucak S., and Kuncic Z. (2015) Molecular dynamics simulations of insulin: elucidating the conformational changes that enable its binding. PLoS One 10, e0144058 10.1371/journal.pone.0144058 PubMed DOI PMC

Kristensen C., Kjeldsen T., Wiberg F. C., Schäffer L., Hach M., Havelund S., Bass J., Steiner D. F., and Andersen A. S. (1997) Alanine scanning mutagenesis of insulin. J. Biol. Chem. 272, 12978–12983 10.1074/jbc.272.20.12978 PubMed DOI

Gauguin L., Delaine C., Alvino C. L., McNeil K. A., Wallace J. C., Forbes B. E., and De Meyts P. (2008) Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I. J. Biol. Chem. 283, 20821–20829 10.1074/jbc.M802620200 PubMed DOI PMC

Mynarcik D. C., Williams P. F., Schaffer L., Yu G. Q., and Whittaker J. (1997) Analog binding properties of insulin receptor mutants. Identification of amino acids interacting with the COOH terminus of the B-chain of the insulin molecule. J. Biol. Chem. 272, 2077–2081 10.1074/jbc.272.4.2077 PubMed DOI

Lawrence M. C., McKern N. M., and Ward C. W. (2007) Insulin receptor structure and its implications for the IGF-1 receptor. Curr. Opin. Struct. Biol. 17, 699–705 10.1016/j.sbi.2007.07.007 PubMed DOI

Ward C. W., Menting J. G., and Lawrence M. C. (2013) The insulin receptor changes conformation in unforeseen ways on ligand binding: Sharpening the picture of insulin receptor activation. Bioessays 35, 945–954 10.1002/bies.201300065 PubMed DOI

Jirácek J., Záková L., Antolíková E., Watson C. J., Turkenburg J. P., Dodson G. G., and Brzozowski A. M. (2010) Implications for the active form of human insulin based on the structural convergence of highly active hormone analogues. Proc. Natl. Acad. Sci. U.S.A. 107, 1966–1970 10.1073/pnas.0911785107 PubMed DOI PMC

Žáková L., Kletvíková E., Veverka V., Lepsík M., Watson C. J., Turkenburg J. P., Jirácek J., and Brzozowski A. M. (2013) Structural integrity of the B24 site in human insulin is important for hormone functionality. J. Biol. Chem. 288, 10230–10240 10.1074/jbc.M112.448050 PubMed DOI PMC

Branduardi D., Bussi G., and Parrinello M. (2012) Metadynamics with adaptive Gaussians. J. Chem. Theory Comput. 8, 2247–2254 10.1021/ct3002464 PubMed DOI

De Meyts P. (1994) The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 37, S135–S148 10.1007/BF00400837 PubMed DOI

Gutmann T., Schaeffer I. B., Poojari C., Brankatschk B., Vattulainen I., Strauss M., and Coskun U. (2019) Cryo-EM structure of the complete and ligand-saturated insulin receptor ectodomain. bioRxiv 10.1101/679233 PubMed DOI PMC

Uchikawa E., Choi E., Shang G., Yu H., and Bai X. C. (2019) Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex. eLife 8, e48630 10.7554/eLife.48630 PubMed DOI PMC

Viková J., Collinsová M., Kletvíková E., Buděšínský M., Kaplan V., Žáková L., Veverka V., Hexnerová R., Tarazona Aviñó R. J., Straková J., Selicharová I., Vaněk V., Wright D. W., Watson C. J., Turkenburg J. P., et al. (2016) Rational steering of insulin binding specificity by intra-chain chemical crosslinking. Sci. Rep. 6, 19431 10.1038/srep19431 PubMed DOI PMC

Křížková K., Chrudinová M., Povalová A., Selicharová I., Collinsová M., Vaněk V., Brzozowski A. M., Jiráček J., and Žáková L. (2016) Insulin-insulin-like growth factors hybrids as molecular probes of hormone:receptor binding specificity. Biochemistry 55, 2903–2913 10.1021/acs.biochem.6b00140 PubMed DOI

Schwieters C. D., Kuszewski J. J., Tjandra N., and Clore G. M. (2003) The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 160, 65–73 10.1016/S1090-7807(02)00014-9 PubMed DOI

Vranken W. F., Boucher W., Stevens T. J., Fogh R. H., Pajon A., Llinas M., Ulrich E. L., Markley J. L., Ionides J., and Laue E. D. (2005) The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59, 687–696 10.1002/prot.20449 PubMed DOI

Shen S., and Bax A. (2013) Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks. J. Biomol. NMR 56, 227–241 10.1007/s10858-013-9741-y PubMed DOI PMC

Van Der Spoel D., Lindahl E., Hess B., Groenhof G., Mark A. E., and Berendsen H. J. (2005) GROMACS: fast, flexible, and free. J. Comput. Chem. 26, 1701–1718 10.1002/jcc.20291 PubMed DOI

Maier J. A., Martinez C., Kasavajhala K., Wickstrom L., Hauser K. E., and Simmerling C. (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696–3713 10.1021/acs.jctc.5b00255 PubMed DOI PMC

Izadi S., Anandakrishnan R., and Onufriev A. V. (2014) Building water models: a different approach. J. Phys. Chem. Lett. 5, 3863–3871 10.1021/jz501780a PubMed DOI PMC

Bonomi M., Branduardi D., Bussi G., Camilloni C., Provasi D., Raiteri P., Donadio D., Marinelli F., Pietrucci F., Broglia R. A., and Parrinello M. (2009) PLUMED: A portable plugin for free-energy calculations with molecular dynamics. Comput. Phys. Commun. 180, 1961–1972 10.1016/j.cpc.2009.05.011 DOI

Mercadante D., Gräter F., and Daday C. (2018) CONAN: A tool to decode dynamical information from molecular interaction maps. Biophys. J. 114, 1267–1273 10.1016/j.bpj.2018.01.033 PubMed DOI PMC

Insulin receptor Arg717 and IGF-1 receptor Arg704 play a key role in ligand binding and in receptor activation

Non-glycosylated IGF2 prohormones are more mitogenic than native IGF2

Recombinant Insulin-Like Growth Factor 1 Dimers: Receptor Binding Affinities and Activation Abilities

A radioligand receptor binding assay for measuring of insulin secreted by MIN6 cells after stimulation with glucose, arginine, ornithine, dopamine, and serotonin

Characterization of viral insulins reveals white adipose tissue-specific effects in mice

A radioligand binding assay for the insulin-like growth factor 2 receptor

Zobrazit více v PubMed

PDB
6HN5, 5U8Q, 5L3L, 6RVA, 4OGA, 4XSS